1Russell
H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins
University School of Medicine, Baltimore, MD, United States; 2Cellular
Imaging Section and Vascular Biology Program, Institute for Cell Engineering,
Baltimore, MD, United States; 3F.M. Kirby Research Center for
Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United
States; 4Department of Neurology, Kennedy Krieger Institute,
Baltimore, MD, United States; 5Russell H. Morgan Department of
Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD,
United States; 6Department of Neuroscience, Kennedy Krieger
Institute, Baltimore, MD, United States; 7JHU In Vivo Cellular
Molecular Imaging Center, The Johns Hopkins University School of Medicine,
Baltimore, MD, United States; 8Division of Cancer Imaging
Research, The Johns Hopkins University School of Medicine, Baltimore, MD,
United States
Neuroimaging has an important role in the diagnosis of tumors, especially to identify different stages of tumor development, the likelihood of metastasis, and the effects of treatment. Recently, Chemical Exchange Saturation Transfer (CEST) MR imaging of natural D-glucose (glucoCEST) was proposed as a novel molecular imaging approach with a biodegradable substrate for tumors. Here we apply this method to visualize glucose uptake in brain tumors, using an orthotopically implanted human brain tumor xenograft in mice. The results show that, using glucoCEST, the tumor glucose uptake can be clearly distinguished from brain glucose uptake.